Phreesia vs Tebra: Which One in 2026?
Medical practices put Phreesia and Tebra on the same spreadsheet because both touch the front desk, both collect money, and both promise less clipboard work. That spreadsheet is the wrong document. One product is built to run everything around the visit on top of a chart the practice already has. The other is built to be the chart, the claim, the schedule, and the reputation page. Neither publishes a list price, so a partner who starts with "what does it cost" will stall before the real question: which job is actually broken.
This page keeps the two jobs separate on purpose. If the practice already has a working chart and the pain is registration, eligibility, copays, and phone traffic, Phreesia is the comparison. If the practice needs one login for notes, claims, scheduling, and new-patient marketing, Tebra is the comparison. Mixing those jobs in one demo is how a clinic buys a second front desk and still cannot close a claim.
TL;DR: Phreesia fits practices that already have a charting system and need intake, payments, and call handling around the visit; Tebra fits independent practices that want EHR, billing, scheduling, and marketing in one login. Neither publishes a price, so the decision is which system of record the practice is willing to live in, not which homepage sounds broader.
How we evaluated
Both products were assessed on six criteria: what system of record they actually are, intake and registration, clinical documentation, claims and patient collections, reputation and new-patient work, and the cost of a conversion month. Public product pages were the source for feature cells. Anything not confirmed on those pages is marked not published. Pricing is quote only for both names. No vendor dollar is printed here.
The reader is a medical practice that has to defend the pick to a physician owner and a billing lead. That is why the criteria come first. A feature that only appears in a sales video was left out.
The visit volume behind the decision is not small. Front-desk software that adds thirty seconds per check-in is a staffing decision, not a preference.
Who Phreesia is built for
Phreesia sells the work around the visit: scheduling, registration, payments, and communication, including a phone agent branded VoiceAI. According to Phreesia, the company cites more than 4,700 healthcare organizations and says it supports 1 in 6 U.S. patient visits. Those are vendor figures. They still explain the buyer: a practice or group that already charts somewhere else and wants the waiting room, the copay, and the inbound call off the clipboard.
The site frames outcomes as time-of-service collections, copay capture, patient-reported data before the visit, and fewer phone holds. It does not present Phreesia as the EHR of record. Practices that treat it as a chart replacement will evaluate the wrong product.
Intake quality is also a clinical problem, not only a billing one. Ambient documentation tools still need a clean registration. What Abridge Means for Healthcare Practices is the adjacent read when the physicians are buying a scribe and the front desk is still on paper.
Who Tebra is built for
Tebra sells an EHR-plus platform for private practices: charting, e-prescribing, telehealth, labs, scheduling, digital intake, two-way messaging, website and reputation tools, eligibility, claims, and patient payments. The company states it is used by a wide range of independent specialties and cites 150,000 providers in its public materials. That is a vendor count. The product shape is the point: one login for clinical, financial, and growth work.
Tebra is the shortlist when the practice does not want a separate intake vendor sitting on top of a separate chart and a separate biller. It is the wrong shortlist when the physicians will not leave an existing EHR and only wanted a better check-in.
AI note assist, review replies, and billing automation are listed on the current product pages. Those features do not remove the conversion cost of moving charts, open claims, and patient balances.
Criteria that actually decide the purchase
If a criterion is not a daily job in the practice, it did not make this table.
| Criterion | Why it matters | What to ask in the demo |
|---|---|---|
| System of record | You cannot have two charts | Does this replace the EHR, or sit in front of it |
| Intake and eligibility | Front desk time is the first bill | Live registration, copay, and coverage check on a real appointment type |
| Clinical documentation | Physicians will veto a slow note | Specialty template, eRx, and a same-day add-on visit |
| Claims and collections | Cash is the second bill | Charge to claim to patient statement without a rekey |
| Reputation and new patients | Independent practices live on reviews | Website, listings, and a review reply on the same login |
| Conversion month | Dual-running is the real cost | Chart history, open AR, and schedule cutover ownership |
Criteria map to jobs medical practices actually staff; demo questions are runnable without a published price.
Phreesia vs Tebra at a glance
| Category | Phreesia | Tebra |
|---|---|---|
| Best fit | Practices with an existing EHR that need intake, payments, and calls | Independent practices that want EHR, billing, and marketing together |
| System of record | Around the visit, not the chart | Cloud EHR plus practice management |
| Intake | Core product: registration, screenings, payments | Digital intake listed inside patient experience |
| Clinical notes | not published as an EHR | EHR with AI-generated notes, eRx, labs, telehealth |
| Claims | Payments and cleaner claims as a front-end outcome | Built-in billing, eligibility, claims, patient pay |
| Marketing / reputation | Communication around the visit | Website, listings, review replies |
| Public pricing | not published | not published |
Feature cells follow each vendor's public product pages; pricing rows confirm no printable figure.
Why the front desk is this expensive
National spend and visit volume are why a "small" intake project is not small. According to CMS, U.S. health spending grew 7.2% to $5.3 trillion in 2024, or $15,474 per person, and accounted for 18.0% of GDP. US health spending reached $5.3 trillion in 2024. According to CMS, physician and clinical services expenditures grew 8.1% to $1,109.7 billion in 2024.
| National health expenditure, 2024 | Figure |
|---|---|
| Total NHE | $5.3 trillion |
| NHE per person | $15,474 |
| Share of GDP | 18.0% |
| Growth vs 2023 | 7.2% |
| Physician and clinical services | $1,109.7 billion |
| Physician and clinical growth | 8.1% |
Historical NHE figures according to the CMS NHE Fact Sheet, page last modified June 24, 2026.
Office traffic is the volume those dollars ride on. According to CDC NCHS FastStats, there were 1.0 billion physician office visits, 320.7 visits per 100 persons, and 50.3% of visits went to primary care physicians. US physician offices logged 1.0 billion visits. Adults who saw a doctor or other professional in the past year: 85.2% in 2024.
| Ambulatory volume | Figure |
|---|---|
| Physician office visits | 1.0 billion |
| Visits per 100 persons | 320.7 |
| Share to primary care | 50.3% |
| Adults with a visit in the past year (2024) | 85.2% |
| Children with a visit in the past year (2024) | 95.1% |
Visit counts according to CDC NCHS FastStats (NAMCS 2019 summary for office visits; NHIS 2024 for the adult and child visit rates).
Prior authorization is the other tax on the same staff. according to American Medical Association, 94% of physicians reported that prior authorization delays access to necessary care, and physicians reported completing an average of 43 prior authorizations per week, consuming the equivalent of 12 hours of physician and staff time. 94% of physicians report prior authorization delays care. That load sits next to check-in, not instead of it.
| Prior authorization burden (AMA survey) | Figure |
|---|---|
| Physicians reporting care delays | 94% |
| Negative impact on clinical outcomes | 93% |
| Patients abandoning treatment | 78% |
| Prior auths per physician per week | 43 |
| Physician and staff hours per week | 12 |
| Physicians reporting more burnout | 95% |
Results according to the AMA prior authorization physician survey press release.
Patients feel the money side even when the practice is insured. According to KFF, 44% of U.S. adults say it is difficult to afford health care costs, and 36% skipped or postponed needed care in the past 12 months because of cost. Time-of-service collections and a clean estimate of what is due are not "nice to have" screens. They are how a practice stays in the room with those patients.
Pros and cons
Phreesia
Pros: built for intake, payments, and communication around a visit the practice already charts elsewhere; public scale claims that match a front-desk buyer; VoiceAI is a published answer to inbound call volume; collections and screening work are the product, not an add-on tab.
Cons: not the EHR of record, so a practice that also needs notes and claims still needs another system; price is quote only; connecting Phreesia to the existing chart is a project, not a toggle.
Tebra
Pros: one login for EHR, billing, scheduling, intake, and reputation; independent-practice buyer is explicit; AI notes and claims tools are on the current product pages; HIPAA, HITRUST, and related marks are published on the site.
Cons: replacing a chart is a longer conversion than adding an intake layer; price is quote only; a practice that only wanted check-in will over-buy if it treats Tebra as "the Phreesia alternative."
What switching actually costs
Ask each vendor for a written quote that lists locations, providers, modules (intake only versus full EHR), implementation, data conversion, training, and what happens when a second site opens. Neither figure is printable here. "Check current pricing on the vendor site" is the honest line, and both sites still send the buyer to a demo.
Phreesia conversions fail when the existing EHR interface is treated as an afterthought. Map appointment types, coverage checks, copay rules, and where the registration lands in the chart before you pick a week. Keep a clipboard fallback for one clinic session until the noon huddle says the tablets held.
Tebra conversions fail when open claims and chart history are promised as "we will migrate you." Demand a list of what moves: problems, meds, allergies, notes, images, balances, and fee schedules. Dual-run the schedule and the claim edit for a full billing cycle. Physicians who cannot find last month's note on Monday will veto the project regardless of the intake screens.
US Tech Automations sits next to whichever product you keep, not inside it. When a visit note or intake packet has to reach a billing queue, US Tech Automations moves the same fields so the biller is not retyping what the patient already entered. That is the same class of problem as connecting a chart to a patient-messaging stack, which is why Gemini Enterprise Agent Platform: What It Means for Healthcare is worth reading before you assume a new AI overlay will file the claim.
Patient-facing language is the other handoff. A portal message, a balance estimate, and a recall text are not the EHR. US Tech Automations can keep those sends on one trail so the front desk is not maintaining three templates, a concern that sits beside Patient-Facing Clinical LLM Explained: What It Changes.
If the practice also wants a written map of intake-to-claim steps after the vendor is chosen, use pricing to put Phreesia or Tebra next to the billing and recall work rather than buying a second login and hoping the noon huddle invents the rest. US Tech Automations does not replace either product. It is the route between the front desk, the chart, and the claim.
The verdict, and who should pick the other one
Pick Phreesia if the physicians are not leaving their EHR and the broken work is check-in, eligibility, copays, and the phone. Judge the demo on a live appointment type and a live coverage check, not on a national visit-share claim.
Pick Tebra if the practice wants one independent-practice stack for notes, claims, schedule, and reputation, and is willing to convert the chart. Judge the demo on a same-day visit, a claim edit, and a review reply, not on a provider-count banner.
If the spreadsheet still lists both as interchangeable, the evaluation failed. They are not interchangeable. One sits around the visit. One is the visit record. A partner who cannot say which job is broken should not sign either quote.
A practical way to keep the two jobs from collapsing is to write two one-page briefs before any demo. Brief one is intake: appointment types, copay rules, eligibility, and where registration lands in the existing chart. Brief two is the chart: notes, eRx, claims, and reputation. If brief one is full and brief two is empty, Phreesia is the meeting. If both briefs are full, Tebra is the meeting, and Phreesia is not a substitute. Bring those pages to the vendor so the demo cannot wander into a product the practice will not implement.
Front-desk staffing should be on that same one-pager. Count how many people check patients in on a Monday morning, how many phones ring at eight, and how many copays are still collected after the patient leaves. Phreesia is bought to change those counts. Tebra is bought to change the note, the claim, and the review. Mixing the counts is how a clinic pays for a second system and still has a clipboard at noon.
FAQs
Do Phreesia and Tebra publish prices?
No. Both are quote only on this page. Ask for locations, providers, modules, implementation, and conversion as separate lines, and do not treat a round number in a deck as a public price.
Is Phreesia an EHR?
Not on the public product pages reviewed here. Phreesia describes scheduling, registration, payments, and communication around the visit. A practice that needs the chart itself is evaluating Tebra, not a Phreesia add-on.
Can Tebra replace a separate intake tool?
Tebra lists digital intake inside its patient-experience tools. Whether that is enough depends on the practice's copay, screening, and eligibility rules. Run those rules in a demo instead of assuming the EHR tab equals a dedicated intake platform.
What should a billing lead demand before cutover?
A list of open claims, unposted charges, patient balances, and clearinghouse enrollment. Dual-run one billing cycle. If the first ERA cannot post, you do not have a go-live.
Will a new intake tool fix prior authorization delays?
No. Prior authorization is a payer process. New check-in software can collect cleaner data. It does not approve the MRI. Staff time on authorizations still has to be scheduled.
How should a partner explain the choice to physicians?
Name the job. If the job is the waiting room and the copay, say Phreesia. If the job is the note and the claim, say Tebra. A combined pitch that claims both is how the physicians stall.
Key Takeaways
Phreesia and Tebra solve different jobs; do not score them as two EHRs or two intake tools.
Neither vendor has a printable public price; both quotes must itemize modules and conversion.
US health spending was $5.3 trillion in 2024, and physician offices still see about a billion visits, so front-desk seconds compound.
Prior authorization already consumes 12 staff-and-physician hours a week in the AMA survey; do not add rekeying on top of that.
Convert intake as a clinic-session test; convert an EHR as a billing-cycle test.
Route note-to-claim and patient-message work outside the vendor login so the noon huddle is not the interface.
About the Author

Helping businesses leverage automation for operational efficiency.